Physician profile
Peter B Stanbro
NPI 1659339224
$1,131.11
in general payments reported to CMS, 2019-2025
17 companies · $34.75 in 2025
The $34.75 reported for 2025 was less than what a typical Child & Adolescent Psychiatry provider received nationally (typical 2025 total: $132).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $314 · 2020: $182 · 2021: $292 · 2022: $43.22 · 2023: $48.36 · 2024: $217 · 2025: $34.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $299.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $332.46 | 2021-2024 | Qelbree, Qelbree |
| Takeda Pharmaceuticals U.S.A., INC. | $204.30 | 2019-2021 | |
| Tris Pharma INC | $142.04 | 2019-2021 | |
| Noven Pharmaceuticals, INC. | $92.34 | 2024 | Xelstrym |
| Neos Therapeutics, LP | $58.06 | 2019-2020 | |
| Ironshore Pharmaceuticals INC. | $57.67 | 2019 | |
| Janssen Pharmaceuticals, INC | $46.80 | 2019-2025 | Invega Sustenna |
| Allergan, INC. | $41.52 | 2019-2020 | |
| Lundbeck LLC | $36.93 | 2019 | |
| Corium, LLC | $21.18 | 2023 | Azstarys |
| E.R. Squibb & Sons, L.L.C. | $18.45 | 2025 | Cobenfy |
| Arbor Pharmaceuticals, INC. | $17.97 | 2019 | |
| Adlon Therapeutics L.P. | $17.75 | 2020 | |
| Vertical Pharmaceuticals, LLC | $17.24 | 2019 | |
| Shire North American Group INC | $15.42 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $10.98 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Stanbro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.